Podcasts about american society

Dealmaking by a pair of pharmas has given the biotech industry its best day of transactions in months, tallying nearly $13 billion in guaranteed payments across two deals. On the latest BioCentury This Week podcast, BioCentury's analysts discuss how the takeout of Blueprint Medicines for $9.1 billion up front gives Sanofi a drug for a rare immunological disorder and bolsters the French pharma's already strong presence in immunology. The analysts also assess the $3.5 billion partnership between BioNTech and Bristol Myers Squibb for an asset targeting cancer's hottest target, PD-(L)1 x VEGF, and underwhelming data from the leading asset against the target, PD-1 x VEGF bispecific ivonescimab, from Summit and Akeso Inc. Those data coincided with the kick-off of the American Society of Clinical Oncology (ASCO) meeting in Chicago, where almost a dozen companies were presenting readouts for another hot target, CLDN18.2. Evopoint is among the companies; its program recently attracted Astellas as a partner. Meanwhile, the biopharma industry is racing to counter the White House's most favored nation drug pricing strategy. BioCentury's Washington analyst, Steve Usdin, explains the urgency and details some of industry's options.View full story: https://www.biocentury.com/article/656097#biotech #biopharma #pharma #lifescience #deals00:00 - Introduction04:39 - Sanofi Buys Blueprint09:22 - BMS-BioNTech20:01 - Hot Targets23:40 - Drug PricingTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

1,522 bridges in Louisiana were rated as being in “poor condition.” That's 12% of the bridges in the state. We break down the report with Norma Jean Mattei, Professor of Engineering at UNO, past president of the American Society of Civil Engineers

At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Katie Schmitz chaired a session on ways to ensure that exercise is part of every cancer treatment plan. She also talked about how results of the CHALLENGE trial in colon cancer might apply to breast cancer. Listen to the episode to hear Dr. Schmitz explain: strategies doctors can use to make exercise an integral part of cancer care how people can afford and stay motivated to exercise the results of the CHALLENGE trial, which found that three years of exercise after colon cancer treatment improved disease-free survival (how long people lived without the cancer coming back) and overall survival (how long people lived whether or not the cancer came back)

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified medical oncologist at the Valley-Mount Sinai Comprehensive Cancer Center in Paramus, NJ, summarizes the top breast cancer research. Listen to the episode to hear Dr. Teplinsky discuss: The SERENA-6 trial, which found that if metastatic hormone receptor-positive, HER2-negative breast cancer develops ESR1 mutations during first hormonal therapy treatment, switching to camizestrant from an aromatase inhibitor before the cancer grows improves outcomes. Results from the DESTINY-Breast09 trial showing that the combination of Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Perjeta (chemical name: pertuzumab) is a better first treatment for metastatic HER2-positive breast cancer than the current standard of THP chemo.  The ASCENT-04/KEYNOTE-D19 trial, which found that people with metastatic, PD-L1-positive, triple-negative breast cancer fared better with the combo of Trodelvy (chemical name: sacituzumab govitecan-hziy) and Keytruda (chemical name: pembrolizumab) as a first treatment compared to people who received chemotherapy and Keytruda.

Los Dres. Isabel Enríquez, Fernando Aldaco y Homero Fuentes, oncólogos médicos mexicanos, comparten su análisis de los estudios más relevantes presentados durante el primer y segundo día de la Reunión Anual 2025 de la Sociedad Americana de Oncología Clínica, celebrada en Chicago, con base en la información disponible al momento de esta grabación.Los trabajos comentados son:BREAKWATER (abstract #LBA3500)CheckMate 8HW (abstract #3501)CodeBreaK 300 (abstract #3540)Abstract #1014Abstract #1015INAVO120 (abstract #1003)DYNAMIC-III (abstract #3503)VERITAC-2 (abstract #LBA1000)ASCENT-04/KEYNOTE-D19 (abstract #LBA109)C-POST (abstract #6001)Fuentes:Abstracts presentados en el marco de la Reunión Anual de la Sociedad Americana de Oncología Clínica (ASCO®) de 2025, Chicago, IL, EE.UU.Material exclusivo para profesionales de la salud. Este material ha sido desarrollado únicamente con fines educativos e informativos y no tiene la intención de sustituir el juicio clínico de los profesionales de la salud.Las opiniones y declaraciones presentadas en este contenido son responsabilidad exclusiva de los ponentes y no reflejan necesariamente la postura institucional de ScienceLink ni de terceros mencionados. La información presentada se basa en el conocimiento y la experiencia profesional de los ponentes. La veracidad, exactitud y actualidad científica de los datos son de su exclusiva responsabilidad. Así mismo garantizan que el contenido utilizado no infringe derechos de autor de terceros y asumen toda responsabilidad por su uso.Se deberán de revisar las indicaciones aprobadas en el país con estricto apego al marco regulatorio aplicable para cada uno de los tratamientos y medicamentos comentados. ASCO® es una marca registrada de la American Society of Clinical Oncology. Este material ha sido producido de manera independiente y no está autorizado, patrocinado ni avalado por dicha organización.

Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma. CME information and select publications here.

Dutch biotech Merus' EGFR x LGR5 bispecific antibody has caught investors' attention in the run-up to ASCO as a new approach to block EGFR signaling. On the latest BioCentury This Week podcast, BioCentury's analysts discuss Phase II data from Merus for petosemtamab as they preview the American Society of Clinical Oncology's upcoming annual meeting. The analysts also assess a setback in a gene therapy trial for Rocket Pharmaceuticals, renewed interest in cancer target EpCAM, and a flurry of biopharma activity on the Hong Kong stock exchange. Finally, the team previews BioCentury's second annual Grand Rounds R&D meeting, which takes place next week in Chicago. This episode was sponsored by Jeito Capital.View full story: https://www.biocentury.com/article/656038#biotech #biopharma #pharma #lifescience #RandD #DrugDevelopment00:01 - Sponsor Message: Jeito Capital24:52 - HK IPOs07:12 - ASCO16:37 - EpCAM20:16 - RocketTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

SHOW NOTESWhat impact does surgery have on the body?Intentional trauma Physiological response Psychosocial impact StressWhen we think about surgery, it's essential to understand that it triggers a significant reaction in the body known as the 'stress response.' This response is a complex interplay of hormonal and metabolic changes directly linked to the degree of tissue damage during surgery. It can intensify if there are any complications after the operation. Let's break it down: The whole process starts when the hypothalamic-pituitary-adrenal axis, or HPA axis, kicks into gear. This leads to a surge in hormones like cortisol, growth hormone, glucagon and catecholamines. These hormones are important because they help the body cope with stress by boosting energy availability and adjusting other bodily functions.Ebb phase (0-48hrs)Increased catabolism of stored glycogen (glycogenolysis)Suppression of insulin secretion → transient hyperglycemiaIncreased catecholamines, cortisol, and inflammatory cytokines (IL-6, TNF-α)Flow phase (3-10 days)Hypermetabolism (increased BMR)Increased protein catabolism → muscle breakdown (to provide amino acids for tissue repair and immune function)Increased lipolysis (fat breakdown) for energySustained insulin resistance → continued hyperglycemiaEnhanced GNG Pro-inflammatory response → increased cytokines and acute-phase protein productionIn the initial stages after surgery, the body releases a wave of pro-inflammatory cytokines. These cytokines jumpstart the healing process by promoting inflammation, which is important for healing surgical wounds. However, to keep this inflammation from going overboard, the body soon follows up with anti-inflammatory cytokines.These inflammatory processes have widespread effects across the body. For example, they can influence how the hypothalamus regulates body temperature or how the liver produces certain proteins that help fight infection and aid in wound healing.But here's where it gets even more interesting: other hormones like glucagon, cortisol, and adrenaline also play a role in modulating these responses. They can affect everything from your blood sugar levels to how your cardiovascular system handles the stress.So, why is all this important? Well, by understanding and managing these responses effectively, we can significantly improve how patients recover from surgery. It's all about helping the body maintain balance during a time when it's incredibly vulnerableDisruption of Metabolic Homeostasis: Surgery often disrupts the body's normal metabolic balance, notably through insulin resistance, where cells fail to respond effectively to insulin, leading to 'diabetes of the injury.' Insulin Resistance and Hyperglycemia: Insulin resistance can cause high blood sugar levels, significantly increasing the risk of surgical complications and mortality. Post-surgery, the body may enter a catabolic state, breaking down muscle instead of fat, which impairs wound healing, weakens the immune system, and reduces muscle strength. Increased Risks for Vulnerable Groups: Elderly, diabetics, and cancer patients are particularly at risk due to their compromised metabolic and inflammatory states. These groups have less physiological reserve, leading to pronounced catabolic states and increased risk of severe post-operative complications. Impact on Recovery and Outcomes: The metabolic chaos from insulin resistance to protein loss not only delays recovery but also exacerbates risks of infection and other complications. Effective management of these changes is crucial for improving surgical outcomes and ensuring that patients thrive post-surgery.ERAS helps to mitigate these by Surgery isn't just about the physical repair or removal of tissue; it triggers a cascade of stress responses in the body that can complicate recovery. These include everything from the psychological impacts of anxiety and the physiological effects of fasting to direct tissue damage and the systemic reactions to it, such as fluid shifts and hormonal imbalances.Key Components of ERAS:Comprehensive Care: ERAS isn't just a single technique but a suite of practices designed to address every aspect of the patient's journey — before, during, and after surgery. This approach aims to minimise the stress responses by controlling pain, reducing fasting times, optimising fluid management, and promoting early mobility.Minimising Fasting: One traditional practice that ERAS revises significantly is the preoperative fasting rule. Old guidelines that required fasting from midnight before surgery are now replaced with more lenient, evidence-based practices that allow intake of clear fluids up to two hours and solids up to six hours before surgery. This change helps maintain normal blood glucose levels, reduces stress, and decreases the body's shift into a catabolic (muscle-degrading) state.Nutritional Optimisation: ERAS protocols emphasise the importance of not entering surgery in a depleted state. By allowing a carbohydrate-rich drink shortly before surgery, patients are better hydrated and less anxious, which in turn reduces insulin resistance and preserves muscle mass — critical factors in speeding up recovery post-surgery. Post-operatively, oral nutrition may be delayed by the medical team until bowel function returns, typically taking close to a week. This delay is stated to reduce postoperative complications such as abdominal distension and nausea/vomiting.For the first several days post surgery fluids of limited nutritional value such as water are provided to patient until tolerance is established leading to insufficient nutrition intake during this time increasing the risk of malnutrition. The ERAS protocol promotes early oral intake within 24 hours post surgery departing from traditional fasting practices. Research suggests that between 40-50% of surgical patients have some degree of malnutrition. Pre-operative malnutrition is an independent predictor of poor post-operative outcomes. Therefore addressing malnutrition is a key component of the ERAS protocol.Immune-Enhancing Diets: Post-surgery nutrition is just as crucial. ERAS encourages diets rich in nutrients that bolster the immune system and enhance wound healing. This includes omega-3 fatty acids, which help modulate the inflammatory response; arginine, which supports protein synthesis and tissue growth; glutamine, which is vital for cellular health and recovery; and nucleotides, which are essential for rapid cell division and immune function .Immuno-nutrition is a specialised medical nutrition therapy that has been shown to adjust the body's inflammatory response: It incorporates specific nutrients like omega-3 fatty acids, arginine, polyunsaturated fatty acids, and nucleotides. It's typically recommended starting 5-7 days before surgery and continuing post-operatively for over 7 days or until oral intake meets at least 60% of the patient's nutritional requirements.How can we use this info to optimize surgical outcomes?Patient education Early nutrition pre and post surgery - Minimise fasting time What is ERAS? How does it differ from traditional care/practice?Introduced by Henrik Kehlet in 1997, the Enhanced Recovery After Surgery (ERAS) protocol has revolutionised surgical practices by optimising perioperative care. A key aspect of ERAS is its interdisciplinary approach, involving healthcare professionals from various specialties to minimise surgical stress and facilitate recovery. What is malnutrition?Malnutrition, is defined as an involuntary reduction in body weight, muscle mass and physical capabilities, affects up to 65% of surgical patients and can worsen during hospital stays. Enhancing nutritional status and promoting functional nutrition therapy is essential, even forpatients without evident malnutrition, particularly when prolonged perioperative oral intake challenges arise. Addressing malnutrition is essential for preventing surgical complications, prolongedhospital stays and higher healthcare costs. What are the benefits of ERAS for the patient?It has been shown that the key physiological benefits include:-enhances the body's anabolic processes-promotes wound healing, which is critical for patient recovery.-Reduces the risk of nutritional depletion-Minimises insulin resistance, a common issue post-surgery, allowing for better blood sugar control and improved metabolic function.-Reduce protein catabolism-And lowers the risk of pressure injuries, which can develop due to extended immobility after surgery.What are the benefits of ERAS from a healthcare perspective? From a healthcare perspective, ERAS has been shown to-shorter length of hospital stay for patients,-Lower risk of ICU transfer rates-reduce readmission rates-And all of these improvements lead to lower healthcare costs, not just for the hospital but for the overall healthcare system, as fewer complications and shorter stays reduce the financial strain.Step 1: Screen & StrengthenIf you've lost any weight unintentionally in the lead up to surgery, or been eating poorly because of a reduced appetite, you may be at risk of malnutrition and it's really important to address this prior to surgery. Research suggests that between 40-50% of surgical patients have some degree of malnutrition. Pre-operative malnutrition is an independent predictor of poor post-operative outcomes. Addressing malnutrition is a key component of the ERAS protocol and why it's effective in improving surgical outcomes for patients.Book an appointment with a dietitian who can guide you on appropriate dietary changes to minimise muscle loss, build you up and optimise nutritional status and stores pre-op. A well-nourished body tolerates surgery better, heals faster, has a stronger immune system to fight infection, and experiences fewer complications.Step 2: Consider Immunonutrition If you're planned for major surgery, especially certain cancer and abdominal surgeries, consider the use of an immunonutrition supplement in the 5-7 days pre op. These are the supplements loaded with arginine, n3s, glutamine and nucleotides to support the immune system and reduce inflammatory responses, potentially leading to fewer infections and better recovery.Step 3: Build Your Strength & Energy Stores prior to surgery Carb load with food in the days leading up to surgery - think that big bowl of pasta a footy player would have the night before the grand final. ERAS protocols have significantly reduced or eliminated long periods of "nil by mouth" (NBM) before surgery.Ask your surgical team exactly when you need to stop eating solid food – it might be much later than you think, often around 6 hours before surgery for a light meal. For clear fluids, it could be as little as 2 hours before!We'll make the most of every second to prevent unnecessary dehydration, hunger, anxiety, and preserve your body's energyStep 4: The Pre-Surgery Carb Load using clear fluidsMany ERAS protocols include a special carbohydrate-rich drink taken a few hours before surgery. Your hospital may provide this, but if they don't, we can organise orders for you or point you in the right direction.  It's usually a clear, sweet drink. Think of it as topping off your fuel tank right before the 'race'."These have been shown to reduce post-operative insulin resistance (which can slow healing), help maintain muscle strength, can reduce nausea, and improve overall wellbeing. It basically tells your body it's in a 'fed' state, not a 'starvation' state, heading into surgery.This is best done with tailor made medical nutrition drinks as they come prepped with the correct doses of maltodextrin-polymer carbs and a lower osmolality than other solutions, which essentially means they gentler on your gut and better for gastric emptying so they don't linger in your gut during surgery. Always follow surgical instructions, but ideally we're aiming for 100 grams of carbohydrate the night before surgery and about 50 grams of carbohydrate in clear fluids approximately 2 hours before anesthesia. This might look like 4 x 200ml drinks the night before, and 2 the morning of surgery If you can't access these drinks, apple or cranberry juice are reasonable replacements.  Drop us an email or message or give us a call if you'd like advice on where to get pre-op and immunonutrition supplement drinks. Then we move on to post op and Step 5 which is aiming to eat early.  ERAS encourages starting to eat and drink as soon as it's safe after surgery – often within hours, not days!As soon as your team says it's okay, try sipping water, then progress to other clear fluids, and then light foods as tolerated. Even small, frequent amounts help. This helps to stimulates your gut to start working again, reducing the risk of ileus – a slow, sleepy bowel, provides energy for healing, and can help you feel more normal, faster.If you haven't been told you can eat or drink, keep asking the question! You are your best advocate! Another tip that can help here is step 6:  Chew GumIf your team allows it, start chewing sugar-free gum several times a day once you're able. It sounds simple, but it can be surprisingly helpful in mimicking eating even when you're not allowed to, and can stimulate your digestive system to return to usual function sooner and reduce the risk of ileus.Step 7 is to Nourish to Heal This is where we bring in our good friend protein to optimise tissue repair and recovery Include protein rich food at each meal, and chat to us if you're finding this difficult because there are plenty of hacks if you're not feeling up to chicken breast and steak! And finally step 8 is to Listen to Your BodyWhile ERAS encourages early eating, we always want you to be tuned in to your body's cues and speaking up to your medical team and us if something doesn't feel right. There are plenty of interventions that can be used to keep you comfortable while still optimising your nutrition to get the best outcomes from surgery. Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., et al. (2021). ESPEN practical guideline: Clinical nutrition in surgery. Clinical Nutrition, 40(7), 4745-4761.Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Laviano, A., Ljungqvist, O., et al. (2017). ESPEN guideline: Clinical nutrition in surgery. Clinical Nutrition, 36(3), 623-650.Gustafsson, U. O., Scott, M. J., Schwenk, W., Demartines, N., Roulin, D., Francis, N., et al. (2019). Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations: 2018. Clinical Nutrition, 38(2), 576-586. (Note: The ERAS® Society website, erassociety.org, is the primary source for the most current and comprehensive suite of procedure-specific guidelines.)Ljungqvist, O., Scott, M., & Fearon, K. C. (2017). Enhanced Recovery After Surgery: A review. JAMA Surgery, 152(3), 292-298.Thiele, R. H., Raghunathan, K., Brudney, C. S., Campos, S., Candiotti, K., Chaves, S., et al. (2016). American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) joint consensus statement on perioperative fluid management in adults. Perioperative Medicine, 5, 26. (Note: This is an example of ASER/POQI consensus; look for other relevant POQI statements on specific surgical procedures and their nutritional components.)Soon, K., Levy, G. M., Cusack, L. A., Varma, S., & Nicholson, G. A. (2020). The effect of preoperative carbohydrate loading on patient outcomes in elective surgery: A systematic review and meta-analysis. Systematic Reviews, 9(1), 254.Lewis, S. J., Egger, M., Sylvester, P. A., & Thomas, S. (2001). Early enteral feeding versus "nil by mouth" after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ, 323(7316), 773-776.Osland, E. J., Hossain, M. A., Khan, S., & Memon, M. A. (2014). Effect of timing of oral feeding on patient outcomes after elective colorectal surgery: A systematic review and meta-analysis. Journal of Gastrointestinal Surgery, 18(5), 1039-1051.Braga, M., Gianotti, L., Nespoli, L., Radaelli, G., & Di Carlo, V. (2002). Nutritional approach in malnourished surgical patients: a prospective randomized study. Archives of Surgery, 137(2), 174-180.Marimuthu, K., Varadhan, K. K., Ljungqvist, O., & Lobo, D. N. (2012). A meta-analysis of the effect of combinations of enhanced recovery after surgery (ERAS) interventions on postoperative outcomes. Annals of Surgery, 255(4), 640-649.

What does success look like in a Chief of Staff role? Hear from EA turned Chief of Staff, Meg Steinschauer, on the unique challenges, KPIs, and opportunities of this career path. Recorded at EA Ignite Fall 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

At the 2025 American Society of Clinical Oncology Annual Meeting, Dr. Samantha El Warrak presented the results of her research on how five lifestyle factors affect the risk of dying from breast cancer.  Listen to the episode to hear Dr. El Warrak explain: the five risk factors included in the study which risk factors were most linked to breast cancer mortality what the results mean for women diagnosed with breast cancer

Featuring an interview with Dr Lindsey Roeker, including the following topics: Clinical development of novel Bruton tyrosine kinase (BTK) degraders in therapy for chronic lymphocytic leukemia (CLL) (0:00) Safety of BTK inhibitors in older and frail patients with CLL (3:41) Utility of minimal residual disease-guided treatment with venetoclax/obinutuzumab (9:20) Impact of the AMPLIFY study of acalabrutinib with venetoclax with or without obinutuzumab in CLL (16:32) Utility of acalabrutinib, venetoclax and obinutuzumab for high-risk CLL (23:31) Emerging data with sonrotoclax and zanubrutinib in treatment-naïve CLL (25:16) Sequencing, tolerability and future development involving pirtobrutinib (25:57) Emerging data with the addition of a BTK inhibitor to chimeric antigen receptor T-cell therapy (32:28) Clinical considerations in the management of Richter's transformation (38:14) Survival outcomes and quality of life for patients with CLL (41:02) Ongoing and future efforts to improve CLL treatment outcomes (45:01) CME information and select publications  

Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia. CME information and select publications here.

Featuring a slide presentation and related discussion from Dr Lindsey Roeker, including the following topics: Recent clinical updates with standard regimens for chronic lymphocytic leukemia (CLL) (0:00) Utility of minimal residual disease-guided treatment intensification after ibrutinib with venetoclax  (7:03) Major long-term findings from the GLOW study of ibrutinib with venetoclax (10:35) Principal findings from the AMPLIFY study of acalabrutinib with venetoclax with or without obinutuzumab (12:28) Findings with combined acalabrutinib, venetoclax and obinutuzumab for patients with previously untreated high-risk disease  (15:52) Early clinical findings with sonrotoclax and zanubrutinib as front-line treatment for CLL (18:12) Principal findings from the BRUIN CLL-321 trial of pirtobrutinib for patients who previously received a covalent Bruton tyrosine kinase (BTK) inhibitor  (19:38) Emerging evidence with pirtobrutinib, venetoclax and obinutuzumab as front-line treatment  (22:15) Novel strategy combining lisocabtagene maraleucel with ibrutinib for relapsed/refractory (R/R) CLL (24:13) Available data with epcoritamab monotherapy for R/R CLL  (26:58) The emerging pharmacologic class of BTK degraders  (29:04) CME information and select publications

The purpose of Evil: A North Korean Christian Refugee Perspective (American Society of Missiology, 2024) is to describe how the North Korean refugee understanding of evil can shape missionary practice in the Korean Peninsula. The central research question guiding this study is, How do North Korean Christian refugees describe evil based on their lived experiences? Twelve North Korean Christian refugees were interviewed. The findings indicate that North Korean Christian refugees understand evil as the oppression of the vulnerable, primarily due to human activities, and as exemplified through governmental actions, human trafficking, and sexual violence. This study also discusses how North Korean refugees understand evil in light of theology, specifically teleology and theodicy, and explores how their understanding resonates with historic Christian beliefs in Korea. Analysis of the interviews provides practical implications for Christian ministry and theodicy as well as the sensitization of practitioners who work with North Korean refugees, specifically, to encourage practitioners to subvert the oppressive narratives that North Koreans are responsible for the evil that befalls them, and to be aware that refugees may have been traumatized by their own compatriots. Dave Broucek is a career practitioner and student of the global mission of the church. He values research into the lesser-known aspects of missions as well as scholarship that addresses the big questions of mission theory and practice. He considers it a privilege to host authors such as Dr. Klejment-Lavin in order to introduce their work to a wider public. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue: “Computer-Aided Design and Manufacturing in Free Fibula Reconstruction of the Mandible: Comparison of Long-Term Outcomes with the Conventional Technique” by Bengur, Humar, Saadoun, et al.  Read the article for FREE: https://bit.ly/CADCAMRecon Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS

In this episode of The Patient From Hell, host Samira Daswani speaks with oncology pharmacist Megan Hartranft about the critical role of oncology pharmacists in cancer care. They discuss the unique responsibilities of oncology pharmacists, the importance of patient education, and the growing field of oral chemotherapy. Megan shares insights on medication adherence, the use of mobile health technologies, and the significance of symptom management in improving patient outcomes. The conversation highlights the need for better integration within healthcare systems and offers practical tips for patients navigating their treatment journey.About Our Guest:Dr. Megan Hartranft is a Clinical Lead with the Clinical and Digital Solutions team, advising on precision oncology products.Prior to joining Labcorp, Dr. Hartranft was a Field Medical Scientific Associate Director at Sanofi, in charge of training for the hematology-oncology medical science liaison team. Earlier as a practicing clinician, she established an oral chemotherapy education program and participated in interprofessional clinics at Rush University Cancer Center. She has also spent time in academia as the oncology faculty member at Rosalind Franklin University of Medicine and Health Sciences, where she maintains an adjunct appointment. Dr. Hartranft is active in several professional organizations, including her roles on the Hematology Oncology Pharmacy Association's Public Policy & Advocacy Committee as well as the American Society of Health System Pharmacy Section of Pharmacy Informatics and Technology Clinical Decision Support and Analytics Advisory Group.BS in Biochemistry/Molecular Biology and BA in Classical Studies - Michigan State University Doctor of Pharmacy - University of North Carolina at Chapel Hill PGY1 Pharmacy Residency - University of Michigan PGY2 Oncology Specialty Residency - University of Georgia/Augusta University Health SystemResources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI research study here: https://pubmed.ncbi.nlm.nih.gov/30964... ‘Integrating Advance Care Planning Videos into Surgical Oncologic Care: A Randomized Clinical Trial'00:00 Introduction to Oncology Pharmacy02:49 The Role of Oncology Pharmacists in Patient Care06:03 Patient Interaction and Education09:09 Exploring Oral Chemotherapy11:45 Adherence to Oral Anti-Cancer Medications15:01 Mobile Health Technologies in Oncology17:58 Symptom Management and Patient Support21:11 The Future of Oncology Pharmacy24:09 Final Thoughts and Tips for PatientsConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Listen Elsewhere: Website: https://mantacares.com/pages/podcast?... YouTube: https://www.youtube.com/@mantacares Spotify: https://open.spotify.com/episode/3TR1... Apple: https://podcasts.apple.com/us/podcast... Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.

"Editor's Corner: Celebrating 50 Years of the American Society of Regional Anesthesia Pain Medicine." From ASRA Pain Medicine News, May 2025. See the original article at www.asra.com/may25news for figures and references. This material is copyrighted.Support the show

Career progression for EAs can be difficult. How can you stand out and break through? This episode offers advice and insights to help you chart your path forward. Recorded at EA Ignite Fall 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

In this episode, Harvard psychologist Dr. Carol Ginandes talks about her groundbreaking research, which demonstrated that hypnosis can accelerate bodily healing. Specifically, Carol's studies found that hypnosis can accelerate wound healing after surgery and bone healing after a fracture.Carol also touches on her work as a fine art photographer, illustrating the connection between heightened states of awareness in both her therapeutic and artistic practices. The episode includes a brief audio sample from Carol's guided hypnotic imagery album (with Hay House),” Rapid Recovery from Injury.”For more on Carol Ginandes and her work, as well as links to reputable hypnosis resources, see below:Carol Ginandes, PhD (on Psychology Today)Carol Ginandes' Audio Programs with Hay House: https://www.hayhouse.com/authorbio/carol-ginandes/Carol Ginandes' Fine Art: https://www.carolginandes.com/American Society of Clinical Hypnosis: https://asch.net/New England Society of Clinical Hypnosis: https://www.nesch.org/Society of Clinical and Experimental Hypnosis: https://www.sceh.us/For more on Traci Stein, and links to her audio programs with Hay House, Hemi-Sync, and on Insight Timer, visit: https://www.drtracistein.com/

Did you know that some weight loss medications can help people lose up to 20% of their body weight, comparable to bariatric surgery outcomes? In this episode, I dive into the latest research comparing two major weight loss medications, Wegovy (semaglutide) and Zepbound (tirzepatide), based on findings from the 72-week SURMOUNT-5 trial. I explain how Zepbound led to greater weight loss (about 20.2% vs. 13.7% with Wegovy), possibly due to its dual action on GIP and GLP-1 receptors. Both drugs were generally well tolerated, with similar side effects like nausea and constipation, though Wegovy had slightly more people stop due to GI issues. I also emphasize that while Zepbound may appear more effective, individual needs, such as cardiovascular health or sleep apnea, should guide treatment decisions. Lastly, I remind you that sustainable weight loss requires patience, realistic expectations, and a holistic approach that includes lifestyle changes, not just medication. Tune in to this episode to learn which weight loss medication might be right for you and why your journey to health is more than just the number on the scale.   Episode Highlights: Comparison of Wegovy (semaglutide) and Zepbound (tirzepatide) Average weight loss outcomes and waist circumference changes between both medications Mechanism of action: GLP-1 vs. dual GIP/GLP-1 receptor targeting Side effect profiles and tolerability of both medications FDA approval differences, including cardiovascular risk reduction and sleep apnea treatment Importance of personalized treatment plans and setting realistic weight loss expectations Ongoing research into oral formulations and long-term safety studies Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Energy infrastructure received a grade of D+ in the 2025 Report for America's Infrastructure, published by American Society of Civil Engineers. Bryce Yonker discusses why the energy sector received a low rating with Michael Miller, vice president of technical services at Exo and a member of ASCE. Miller says the four main factors that contributed to the grade include higher load growth, systems operating closer to limits, challenges to distribution grids, and the public's lower tolerance for power outages. Miller discusses best practices for asset inspections, the need to have a national standards, and how state legislatures can have a positive impact on hardening America's energy infrastructure. You can read the full report here.

“Using electromagnetic induction to inform precision turfgrass management strategies in sand-capped golf course fairways” with Dr. Briana Wyatt and Dallas Williams Golf courses are well known for their beautiful greens, but overusing fertilizer and water to keep them looking pristine can lead to inefficient, expensive, and environmentally damaging waste. Precision turfgrass management can help, but only if we can find the right methods to put it into use. In this episode, Briana and Dallas join me to discuss their research on how electrical conductivity can be used to help determine golf course needs. Tune in to learn: ·         How many management zones might be in a fairway ·         How turfgrass type can effect electromagnetic induction correlations ·         Which properties are most correlated with electromagnetic induction readings ·         How researchers can get readings on large areas of a golf course fairway If you would like more information about this topic, this episode's paper is available here: https://doi.org/10.1002/agg2.70020 This paper is always freely available. Contact us at podcast@sciencesocieties.org or on Twitter @FieldLabEarth if you have comments, questions, or suggestions for show topics, and if you want more content like this don't forget to subscribe. If you'd like to see old episodes or sign up for our newsletter, you can do so here: https://fieldlabearth.libsyn.com/. If you would like to reach out to Briana, you can find her here: briana.wyatt@tamu.edu If you would like to reach out to Dallas, you can find her here: dmwilliams22@tamu.edu Resources CEU Quiz: https://web.sciencesocieties.org/Learning-Center/Courses/Course-Detail?productid=%7bD35BC10D-F821-F011-9989-000D3A32C099%7d Transcripts: https://www.rev.com/app/transcript/NjgyNGU4NmRkZjIzY2FlOWRmYTQ4ZmEwV2Y5WFhuVTFpTnR3/o/VEMwODY4NTQyOTM4 TAMU turfgrass website: https://soilcrop.tamu.edu/research/turfgrass/ TAMU Department of Soil and Crop Sciences Facebook: https://www.facebook.com/tamusoilcrop TAMU Department of Soil and Crop Sciences Twitter: https://x.com/tamusoilcrop Thank you to our volunteer Om Prakash Ghimire for help with the shownotes and other assets. Thank you to Cole Shalk from 12twelve Media for the Audio Processing on today's episode. Field, Lab, Earth is Copyrighted by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America.

How would you describe “longevity” to your patients? We've got an expert who can help. This week, we're just joined by Dr. Doris Day as she walks us through the concept of longevity. Listen in as she discusses diet, medications, psoriasis, eating schedules, the mTOR pathway, and why it makes sense to spoil your appetite. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.   Doris Day, MD, is a board-certified dermatologist who specializes in cosmetic dermatology on the Upper East Side in New York City. She is a clinical professor of dermatology at the New York University Medical Center, where she received the Award for Dedication and Excellence in the Teaching of Dermatology. She has also been honored with the American Skin Association Award for Mentorship in Dermatology and the AAD Presidential Citation in recognition of her dedication and leadership in the field of aesthetic dermatology. Most recently, she was named the #3 Top Cosmetic Dermatologist in the U.S. by Newsweek. Dr. Day has received awards for her work in laser research and continues to actively participate in FDA clinical trials and publish in peer-reviewed medical journals. She regularly lectures both nationally and internationally to peers and the public. She is an active member of numerous professional organizations, including the American Society for Dermatologic Surgery and the American Academy of Dermatology, where she has served on the Board of Directors. She also holds a master's degree in medical journalism and has hosted The Dermatology Show on Doctor Radio (SiriusXM 110) for over 15 years. In addition to frequent appearances on national media and podcasts, she is the author of four books—her most recent titled Rebooting the Biome.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue: “Legislative Impact and Persistent Disparities: Postmastectomy Breast Reconstruction Rates in the United States among 224,506 Patients” by Schafer, Ho, Potoczak, et al. Read the article for FREE: https://bit.ly/LegislativeReconRate Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS

For over 20 years, Shannon and her team at TriStar Pension Consulting have acted as a secret weapon for financial advisors, CPAs, small businesses, and plan sponsors. They are the go-to resource for plan design, fixing broken retirement plans, client presentation support, and high-touch customer service.Since starting the firm over two decades ago, her goal has been to provide a deeper level of retirement plan knowledge and service for clients, as well as a flexible workplace for employees. Today, they are one of the leading providers of retirement plan administration for small businesses.Shannon is a credentialed member of the American Society of Pension Professionals and Actuaries (ASPPA) and the National Institute of Pension Administrators (NIPA). She currently serves on the ASPPA Leadership Council and as a member at large on the board of directors of the American Retirement Association (ARA). Shannon co-chaired the ARA Women in Retirement Conference (WiRC) as well as the ASPPA TPA Growth Summit. She has also served on several fundraising committees and supports many non-profits locally, such as Infant Crisis Services, Make a Wish Oklahoma, and Cleats for Kids.If you are a financial advisor, CPA, or business owner with retirement plan questions, please be sure to connect with Shannon on LinkedIn. You can also email her at shannon@tristarpension.com.In this episode, Eric and Shannon Edwards discuss:Courtroom insights reveal real fiduciary risks Unlicensed, unbiased guidance fills a critical gap Military backgrounds bring strategic value to finance Proactive planning improves outcomes Key Takeaways:Litigation shows that inadequate documentation, unclear investment policies, and ignoring DOL guidance are common pitfalls that expose plan sponsors to ERISA lawsuits.By operating outside traditional financial licenses, 90 North Consulting offers compliance-free, litigation-informed fiduciary support tailored to plan sponsors' needs.The transition from service member to financial consultant highlights the adaptability, discipline, and leadership needed to navigate complex regulatory environments.Fostering financial literacy, implementing debt management strategies, and engaging in continuous plan improvement can close the retirement savings gap and safeguard both employees and employers.“[The single most overlooked risk is doing nothing]. There's a risk in sticking with the status quo and not looking at how to make your plan better." - Eric DysonConnect with Shannon Edwards:Website: https://www.tristarpension.com/ LinkedIn: https://www.linkedin.com/in/shannonedwardsplanconsultant/ Connect with Eric Dyson: Website: https://90northllc.com/Phone: 940-248-4800Email: contact@90northllc.com LinkedIn: https://www.linkedin.com/in/401kguy/ The information and content of this podcast are general in nature and are provided solely for educational and informational purposes. It is believed to be accurate and reliable as of the posting date, but may be subject to change.It is not intended to provide a specific recommendation for any type of product or service discussed in this presentation or to provide any warranties, investment advice, financial advice, tax, plan design, or legal advice (unless otherwise specifically indicated). Please consult your own independent advisor as to any investment, tax, or legal statements made.The specific facts and circumstances of all qualified plans can vary, and the information contained in this podcast may or may not apply to your individual circumstances or to your plan or client plan-specific circumstances.

Are you an admin or EA looking to add more project management skills to your toolkit? Crystal Richards, PMP shares her tips and considerations for getting started as an administrative project manager. Recorded at EA Ignite Fall 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Check out Dr. Mina's top picks for skin care here. In this conversation, Dr. Mina and Dr. Nicole Salame delve into the complexities of laser treatments in dermatology. They discuss the nuances of different laser technologies, the importance of provider expertise, and the safety considerations for patients. The conversation also highlights the need for patients to be informed about their providers' credentials and the specific lasers suitable for various skin types. Additionally, they explore innovative uses of lasers in treating medical conditions like skin cancer, emphasizing the potential benefits and limitations of these treatments.    Key Takeaways: Lasers are customizable devices that target specific skin issues. Provider expertise is crucial for safe and effective laser treatments. Misconceptions about lasers being simple can lead to complications. Patients should prioritize safety and provider qualifications. Darker skin types can safely receive laser treatments with the right technology. Intense pulse light is risky for darker skin types. Lasers can be used innovatively for treating skin cancers. Understanding laser physics is essential for effective treatment. Patients should be aware of the potential for complications. Choosing the right provider can minimize risks and enhance outcomes. Patients often feel exhausted from frequent skin treatments. Laser resurfacing can treat precancers and rejuvenate skin. Non-ablative and ablative lasers are effective for skin health. Regular laser treatments can reduce skin cancer incidents. Choosing a board-certified dermatologist is crucial for skin care. A holistic approach to skin health leads to better results. De-influencing trends in skincare is important for patients. Innovative devices are changing the landscape of dermatology. The future of dermatology includes regenerative treatments. Understanding the difference between medical and cosmetic treatments is key. In This Episode: 03:06 Understanding Laser Technology 05:49 The Importance of Provider Expertise 09:10 Navigating Patient Safety and Complications 12:11 Choosing the Right Provider 15:04 Lasers for All Skin Types 18:00 Innovative Uses of Lasers in Medicine 22:30 The Emotional Toll of Skin Treatments 23:10 Laser Treatments for Skin Cancer Prevention 26:28 Choosing the Right Laser Treatment 31:08 The Importance of a Trusted Dermatologist 33:02 Innovations in Laser Technology 36:10 The Future of Regenerative Dermatology   Nicole Salame, MD, FAAD is a double board-certified and fellowship-trained cosmetic dermatologist and Mohs micrographic surgeon. She attended college at the University of California, Los Angeles (UCLA) on numerous scholarships, graduating Cum Laude. She earned her MD from the University of California, Irvine (UCI) School of Medicine with induction into the Alpha Omega Alpha (AOA). She completed her dermatology residency at Emory University where she served as Chief Resident. Dr. Salame then completed an American Society of Dermatologic Surgery (ASDS)-accredited fellowship in Cosmetic Dermatologic Surgery at the prestigious SkinCare Physicians under the exceptional mentorship of innovators in the field. Dr. Salame is a Fellow of the American Academy of Dermatology (AAD), serves on several committees for the American Society for Laser Medicine and Surgery (ASLMS), and is an active member of the ASDS and Women's Dermatology Society (WDS). She has been a sub-investigator for numerous clinical trials and serves as a peer reviewer for Dermatologic Surgery and JAMA Dermatology. Her scholarly work has culminated in the authorship of over 30 peer-reviewed manuscripts and book chapters and more than 40 presentations at national conferences. Her expertise includes medical, procedural, and cosmetic dermatology with specialized-training in lasers, energy-based devices, injectables, regenerative dermatology, rejuvenation, and pre-juvenation.   Follow Dr. Salame here: https://www.drnicolesalame.com/ https://www.instagram.com/dr.nicolesalame/   Follow Dr. Mina here:-  https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin https://www.linkedin.com/in/drminaskin/ For more great skin care tips, subscribe to The Skin Real Podcast or visit www.theskinreal.com Baucom & Mina Derm Surgery, LLC Website- https://www.atlantadermsurgery.com/ Email - scheduling@atlantadermsurgery.com Contact - (404) 844-0496 Instagram - https://www.instagram.com/baucomminamd/ Thanks for listening! The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice.

Episode 200 is a celebration of your journey and questions, as I dive deep into the realities of weight loss, medications, and staying consistent through it all. In this episode, I celebrate a huge milestone—our 200th episode of the Back on Track: Achieving Healthy Weight Loss podcast! I take this opportunity to answer your most frequently asked questions from TikTok, YouTube, Instagram, and podcast listeners, covering a wide range of topics like weight loss medications (such as Qsymia and Contrave), combining medications, insurance, PCOS, managing side effects, and more. I also dive into important issues like long-term use of medications, how they affect hormones and metabolism, dealing with weight loss plateaus, and how shift work and mindset can impact progress. Furthermore, I share tips for staying consistent and remind you that small steps matter on this journey.  Celebrate 200 episodes of transformative weight loss advice with me and tune in now for expert answers to your most pressing health and weight loss questions!   Episode Highlights: Frequently asked questions about weight loss medications like Qsymia and Contrave Comparison between Qsymia, Contrave, and GLP-1 medications Medication safety regarding Lexapro, alcohol, and pregnancy Understanding PCOS and insulin resistance in weight management Addressing muscle loss and weight plateaus during weight loss Strategies to manage hunger with shift work and circadian rhythm disruptions Overcoming the “all or nothing” mindset for long-term consistency and success Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd   About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

Jennifer McNelly, CAE, CEO of the American Society of Safety Professionals (ASSP), discusses the Intersociety Forum (ISF) and a recent report calling for a shift in how safety is embedded in business strategy. Representing nearly 30 safety and health organizations, the ISF advocates moving beyond legal compliance toward risk-based, proactive safety management systems. Jennifer explores why compliance alone hasn't lowered fatality rates and how industry consensus standards, predictive data insights, and integrated safety strategies can drive better outcomes—not just for workers, but for business performance. She also highlights why now is the time for unity and how safety professionals can become influential change agents within their organizations. This conversation is packed with actionable insights for safety leaders looking to align safety and strategic value—and to help shape the future of workplace protection.

"If you can think your way into an illness, can you think your way out? The answer is yes." - Dr. Ran Anbar Dr. Ran Anbar is a renowned board-certified pediatric pulmonologist and general pediatrician who specializes in hypnosis and counseling. He operates out of Centerpoint Medicine in La Jolla, California, and Syracuse, New York. As a past president, fellow, and approved consultant of the American Society of Clinical Hypnosis, Dr. Anbar has authoritatively contributed to the field with his acclaimed books, which explore hypnosis as a transformative healthcare practice, particularly for children and teens. Episode Summary: In this engaging episode of "Oh, My Health… There's Hope!", host Jana Short sits down with Dr. Ran Anbar, an esteemed expert in pediatric pulmonology and the therapeutic use of hypnosis. Dr. Anbar shares his intriguing journey into hypnosis, sparked by a compelling case 27 years ago, and how it has evolved into a significant aspect of his practice today. He highlights the potential of imagination in children's healthcare and its pivotal role in treating various chronic conditions and emotional disorders. Throughout the podcast, Dr. Anbar delves into the profound impact of hypnosis on treating children's ailments, such as allergies, autoimmune diseases, and anxiety. Emphasizing the mind-body connection, he elaborates on how children can leverage their imagination and mental focus to alleviate symptoms. This episode provides insightful discussions on overcoming biases towards hypnosis and integrating it as a safe and beneficial mode of therapy for emotional regulation. It concludes with valuable parenting tips about supporting children's independence and the importance of effective communication. Key Takeaways: Hypnosis is a powerful tool that utilizes imagination to manage and improve health conditions, including asthma and anxiety, especially in children. The mind-body connection is crucial in addressing chronic illnesses, where emotional regulation becomes a key component of healing. Encouraging teens to make their own decisions reinforces independence and supports their path to becoming well-adjusted adults. Parents should transition from enforcing to supporting roles, fostering an environment where children feel empowered to manage their challenges. Techniques like color association and mindful breathing are practical tools suggested by Dr. Anbar to help ease pain and anxiety. Resources www.centerpointhypnosis.com www.linkedin.com/in/ran-anbar-246b1829 Get in touch with Jana and listen to more podcasts: https://www.janashort.com/ Show Music ‘Hold On' by Amy Gerhartz: https://www.amygerhartz.com/music. Get the Best Holistic Life Magazine Subscription! One of the fastest-growing independent magazines centered around holistic living. https://bestholisticlife.info/Subscription Grab your gift today: https://www.janashort.com/becoming-the-next-influencers-download-offer/ Connect with Jana Short: https://www.janashort.com/contact/

Featuring an interview with Dr John P Leonard, including the following topics: First-line therapy for diffuse large B-cell lymphoma (DLBCL) with polatuzumab vedotin and R-CHP; impact of DLBCL cell of origin (0:00) Epcoritamab, glofitamab and other bispecific antibodies as initial therapy for large B-cell lymphoma (9:27) Sequencing chimeric antigen receptor T-cell therapy and bispecific antibodies for patients with relapsed/refractory (R/R) DLBCL (12:30) Approved and investigational bispecific antibodies for the treatment of DLBCL (15:24) Practical considerations for the administration of mosunetuzumab (22:03) Tafasitamab combined with lenalidomide/rituximab as second-line treatment for follicular lymphoma (FL); third- and later-line therapy options (24:33) Activity of Bruton tyrosine kinase inhibitors in FL and other non-Hodgkin lymphomas (31:27) Risk of infection for patients receiving bispecific antibodies (33:23) Chemotherapy-free regimens for the treatment of mantle cell lymphoma (MCL) (36:21) Current role of transplant in the treatment algorithm for MCL; potential integration of bispecific antibodies into therapy for R/R disease (41:23) Myths and misperceptions about the management of DLBCL, FL and MCL (47:29) CME information and select publications

Dr John P Leonard from Weill Cornell Medicine in New York, New York, reviews data presented at the 2024 ASH Annual Meeting and their implications for the treatment of non-Hodgkin lymphomas. CME information and select publications here.

Featuring a slide presentation and related discussion from Dr John P Leonard, including the following topics: Five-year analysis of the POLARIX trial of polatuzumab vedotin with R-CHP for previously untreated diffuse large B-cell lymphoma (0:00) Epcoritamab, glofitamab and other bispecific antibodies for large B-cell lymphoma (5:33) Circulating tumor DNA as an early outcome predictor in patients with large B-cell lymphoma receiving second-line lisocabtagene maraleucel in the TRANSFORM study (16:44) The bispecific antibodies mosunetuzumab and odronextamab as initial therapy for follicular lymphoma (FL) (19:27) The Phase III inMIND trial of tafasitamab in combination with lenalidomide/rituximab for recurrent FL (22:58) Updated results from studies of bispecific antibodies and chimeric antigen receptor T-cell therapy for relapsed/refractory FL (24:58) Updates from the Phase III TRIANGLE and ECOG-ACRIN EA4151 trials on the role of autologous stem cell transplant in the treatment of previously untreated mantle cell lymphoma (MCL) (27:48) Novel treatment approaches with Bruton tyrosine kinase inhibitors for patients with newly diagnosed MCL (30:53) CME information and select publications

In this episode, Toby Gilk returns to discuss the intriguing and complex world of MRI technology. Learn about the role of superconductivity in MRI machines, the potential hazards of quench pipes, and the importance of proper design to prevent catastrophic failures. Toby explains how superconductivity allows MRI machines to operate efficiently without continuous power but also introduces risks if not managed correctly. Hear about real-world examples of quench pipe failures and the engineering solutions that mitigate these dangers, and gain insights into the latest advancements in MRI technology and how they impact safety protocols in healthcare facilities.   Sponsored by:   American Society for Health Care Engineering (ASHE): Optimizing health care facilities      Link to show notes: https://fgiguidelines.org/podcast/s2-e8-mri-quench-pipes-engineering-challenges-and-safety-solutions Learn more about AIA self-reporting LUs: https://fgiguidelines.org/aia-self-reporting-lus/  Connect with us on LinkedIn

Did you know that simply tracking your steps each day can double your chances of reaching your weight loss goals? In this episode, I explored how digital tech tools like fitness trackers, heart rate monitors, smart scales, continuous glucose monitors (CGMs), streaming fitness apps, and sleep tech can support your weight loss journey. I shared personal experiences using devices like the Fitbit, Apple Watch, and Garmin, emphasizing how they helped me stay accountable and understand my body's needs better. From real-time data on your activity and heart rate to insights on your sleep and glucose levels, these tools offer valuable support—but they're not without downsides, such as cost, data accuracy, and the risk of obsession. Ultimately, I encouraged picking one or two tools based on your biggest challenges and reminded my listeners that while tech can help, real progress still depends on showing up and staying consistent.  Tune in to discover which digital tools can supercharge your weight loss journey and help you stay on track effortlessly!   Episode Highlights: Benefits and drawbacks of fitness trackers  How heart rate monitors help optimize fat burn and endurance training Insights from smart scales on body composition beyond weight Role of continuous glucose monitors (CGMs) in personalized nutrition Advantages and limitations of streaming fitness apps Impact of sleep tech on metabolism and weight loss Integration of digital tools through platforms like Apple Health and MyFitnessPal Tips for choosing the right tech based on your biggest health challenge Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue: “The Financial Impact of a Cosurgeon in Breast Microsurgery” by DeVito, Ke, Park, et al. Read the article for FREE: https://bit.ly/CosurgeonFinance Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS

In this episode of the DermSurgery Digest, you'll hear a summary of the surgical oncology and reconstruction articles in the May 2025 issue of Dermatologic Surgery followed by commentary from special guest contributors Min Deng, MD, and Erica Leavitt, MD. This podcast is hosted by Dermatologic Surgery Digital Content Editor, Naomi Lawrence, MD, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery. In this podcast series the cosmetic and general dermatology articles in the May issue of Dermatologic Surgery are featured in a separate episode. Your feedback is encouraged. Please contact communicationstaff@asds.net. 

In this episode of the DermSurgery Digest, you'll hear a summary of the cosmetic and general dermatology articles in the May 2025 issue of Dermatologic Surgery followed by commentary from special guest contributors Kimberly Butterwick, MD, and Megan McClean, MD. This podcast is hosted by Dermatologic Surgery Digital Content Editor, Naomi Lawrence, MD, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery. In this podcast series the surgical oncology and reconstruction articles in the May issue of Dermatologic Surgery are featured in a separate episode. Your feedback is encouraged. Please contact communicationstaff@asds.net.

Paul Williams is an Oscar, Grammy, and Golden Globe award-winning composer, songwriter, and musician. He is known for writing and co-writing popular songs such as “Evergreen”, “We’ve Only Just Begun”, and “Rainbow Connection”. Williams wrote the score and lyrics for renowned films such as the 1976 adaptation of “A Star is Born”, “The Muppet Movie”, “The Muppet Christmas Carol”, “Bugsy Malone”, and “The Phantom of the Paradise”. His songs have been recorded by legendary artists such as Frank Sinatra, Elvis Presley, and The Carpenters. As an actor, Williams has appeared in numerous high profile films and TV shows such as the 1973 “Battle for the Planet of the Apes”, “Smokey and the Bandit”, “Phantom of the Paradise”, and “Baby Driver”. His illustrious career spans generations and includes titans of both the music industry and Hollywood. Currently, Williams is the president and chairman of the ASCAP, the American Society of Composers, Authors, and Publishers.See omnystudio.com/listener for privacy information.

Do you understand your business and the value you add as an admin or EA? Listen to this episode if you want to start elevating your financial and business acumen for career advancement. Recorded at EA Ignite Fall 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

La Academia Americana de Pediatría define la obesidad en niños y adolescentes como un Índice de Masa Corporal igual o superior al percentil 95 para su edad y sexo. Esto significa que el peso del niño es mayor del esperado para su altura y edad, lo que puede indicar un exceso de grasa corporal. Hoy en día existen tratamientos o intervenciones que han demostrado ser más efectivos y seguros en el manejo de la obesidad infantil y de eso hablamos hoy con el Dr. Fernando Pérez Galaz, reconocido cirujano especializado en cirugía gastrointestinal y cirugía bariátrica, egresado de la Universidad Anáhuac, donde también cursó la Maestría en Ciencias Médicas. Actualmente, el Dr. Pérez Galaz es Director de la Clínica Gastro Bariátrica Santa Fe en el Hospital ABC Santa Fe, la única clínica en México certificada por la EASO (European Association for the Study of Obesity). El Dr. Pérez Galaz es autor del libro "50 preguntas en cirugía y tratamiento farmacológico de la obesidad". Su labor académica incluye ser docente en la Universidad Iberoamericana, en la especialidad de Obesidad y Comorbilidades, y profesor auxiliar de la especialidad de cirugía general en el Hospital ABC. Además es miembro del American College of Surgeons y del American Society for Metabolic and Bariatric Surgery. Además de su práctica médica, es cofundador de la Fundación Obesidades, una organización sin fines de lucro que busca lograr el reconocimiento de la obesidad comoenfermedad crónica y la no discriminación del paciente que vive con esta enfermedad. Actualmente, el Dr. Pérez Galaz es anfitrión del podcast Bariatría PRO, en el que imparte medicina basada en evidencia para mejorar la salud de forma inteligente. Instagram: @‌drperezgalaz Podcast: Bariatría Pro ¿Tienes algún comentario sobre este episodio o sugerencias de temas para un futuro podcast?  Escríbenos a pediatrasenlinea@childrenscolorado.org.

On this episode of Talking Away The Taboo, Estie Rose, MS, CGC, Heather Hipp, MD, and Gail Heyman, join Aimee Baron, MD for the second episode of our 5-part IWSTHAB x JSCREEN Podcast series is all about Fragile X. When people think of genetic testing before pregnancy, they often think of Tay-Sachs or cystic fibrosis—but Fragile X is just as important and far less understood. In this episode, Estie Rose and Dr. Heather Hipp explain the difference between recessive and X-linked conditions, what it means to be a Fragile X carrier, and how it can affect fertility and family planning. We also hear from Gail Heyman, who shares her deeply personal journey navigating Fragile X in her own family—and how that led her to advocacy. Whether you're building your family or supporting someone who is, this episode is filled with insight, honesty, and heart. -Click here to watch Part 1: Introduction to Genetics and Infertility More about Estie:  Estie Rose is a certified genetic counselor at jscreen. She has a special interest in community education and serves as a resource for individuals who are facing genetic health issues. Connect with Estie:  -Follow her on Instagram More about Heather: Dr. Heather Hipp is a Reproductive Endocrinology and Infertility (REI) physician and an Associate Professor at Emory University School of Medicine. She earned her undergraduate degree at Duke University and then her MD degree at Emory University, where she continued her training in residency and fellowship. She is the Program Director for the REI fellowship at Emory and serves as chair for the American Society for Reproductive Medicine Education Committee. Her profession memberships include American College of Obstetrics and Gynecology, American Society for Reproductive Medicine, Alpha Omega Alpha Honor Society, and American Gynecological & Obstetrical Society. She is also on the National Fragile X Foundation Scientific and Clinical Advisory Committee. Her research focuses on women who are carriers for the fragile X mutation and their risk of premature ovarian insufficiency, as well as trends and outcomes of in-vitro fertilization (IVF) in the United States. More about Gail:   Gail Heyman is a passionate advocate and leader in the Fragile X community. After her son was diagnosed in 1989, she co-founded the Fragile X Association of Georgia and has served as its director ever since. Her family's experience—spanning three generations affected by Fragile X conditions—fuels her tireless work to raise awareness, promote research, and support others navigating similar challenges. Gail also serves on JScreen's advisory board and has received national recognition for her leadership in genetic advocacy and inclusion. -Click here to learn more about Gail's story -Check out Carly Heyman's book, My eXtra Special Brother -Learn more about Fragile X here Connect with JScreen:  -Visit their website -Coupon Code: IWSTHAB18 for $18 off initial testing (no expiration date on this offer) -Follow JScreen on Instagram Connect with us:  -Check out our Website - Follow us on Instagram and send us a message -Watch our TikToks -Follow us on Facebook -Watch us on YouTube

In this interview episode, I'm joined by author, crime historian, broadcaster and keynote speaker N. Leigh Hunt.A member of the American Society of Criminology, Nick is regarded as an expert on mass shootings and school attacks. He was recognised at the inaugural True Crime Awards with a Highly Commended Award in the Best New Crime Author category for his book

Are you feeling the weight of perfectionism and the constant need to achieve? Dr. Tiffany Moon's journey is a testament to how the pressure to be perfect can hinder personal fulfillment. As a successful physician, reality TV star, and author, she realized that her life was driven by external accomplishments rather than internal joy.  In this episode, Dr. Tiffany shares how she stopped living for external validation and began to align her actions with her authentic self. From moving away from toxic friendships to learning the art of saying no, she highlights the importance of setting boundaries and prioritizing well-being over societal expectations.  Her book, Joy Prescriptions, explores this journey and how Dr. Tiffany applied her doctor's mindset to prescribe joy in everyday life. It's not just about removing the negative but creating space for what truly brings happiness.  Ready to start your own journey of self-rediscovery? Join us as we explore how you can overcome perfectionism, prioritize joy, and live a life that feels as good on the inside as it looks on the outside.  "To stop filling your bucket with the wrong things is a mindset shift. First, you change your mindset, and then you start doing things that fall in line with the new mindset." ~ Dr. Tiffany Moon In this Episode: - Meet Dr. Tiffany Moon - Behind the scenes of the Real Housewives of Dallas - Jen's Real Housewives experience - Dr. Tiffany's upbringing, academic achievements, and career - Escaping the trap of perfectionism and reconstructing Life - Finding healing: therapy, self-help books, and a "friends" audit - Tiffany's Real Housewives experience  - Dr. Tiffany's life and career after her awakening - How to pre-order the Joy Prescriptions book  About Dr. Tiffany Moon: Dr. Tiffany Moon is a board-certified anesthesiologist, entrepreneur, and author. She is a proud mother of twins and a dynamic television and social media personality. Dr. Tiffany graduated from Cornell University at 19, earned her medical degree with Alpha Omega Alpha Honors from UT Southwestern, and completed her anesthesiology residency at UCSF. She has been named one of D Magazine's Best Doctors, authored over 50 peer-reviewed publications, been recognized as a Distinguished Educator by the American Society of Anesthesiologists, and serves as an Oral Board Examiner for the American Board of Anesthesiology. She is the founder and CEO of Aromasthesia Candle Company, Three Moons Wine, and LeadHer Summit. Her debut book, Joy Prescriptions—a powerful exploration of overcoming perfectionism and finding joy through gratitude, self-compassion, and connection—will be published in May 2025. Pre-order Joy Prescriptions: https://www.joyprescriptions.com/  Website: https://www.tiffanymoonmd.com/  Instagram: https://www.instagram.com/tiffanymoonmd/  Facebook: https://www.facebook.com/tiffanymoonmd  Where to find me: IG: https://www.instagram.com/jen_gottlieb/    TikTok: https://www.tiktok.com/@jen_gottlieb     Facebook: https://www.facebook.com/Jenleahgottlieb    Website: https://jengottlieb.com/    My business: https://www.superconnectormedia.com/     YouTube: https://www.youtube.com/@jen_gottlieb

Curious about the chemistry of cocoa? We've got just the expert. This week, we're joined by Dr. Zoe Diana Draelos as she talks cocoa like you've never heard before. Listen in as she walks through the latest research, cocoa's application in oral and topical treatments, and where it's headed. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Catch Dr. Draelos live at IDS2025 for more on cocoa in dermatology! View Agenda: https://bit.ly/42joj2r Zoe Diana Draelos, MD, is a research and clinical board-certified dermatologist and a Fellow of the American Academy of Dermatology. She is in solo private practice in High Point, North Carolina, and a Consulting Professor of Dermatology at Duke University. In 1988, she founded Dermatology Consulting Services, PLLC, to initiate and perform research in aging skin, acne, rosacea, psoriasis, atopic dermatitis, actinic keratoses, eczema, and aesthetic procedures in the cosmetic, OTC drug, and pharmaceutical arenas. Prior to pursuing a medical career, Dr. Draelos completed an undergraduate degree in Mechanical Engineering and was elected a Rhodes Scholar. A member of Sigma Xi research honorary and Alpha Omega Alpha medical honorary, she is author of 14 books including Cosmetics in Dermatology (fourth edition) and Hair Cosmetics. She is the editor of Cosmetic Dermatology: Products and Procedures (third edition) and Cosmeceuticals (fourth edition) with translations into 7 languages. She has contributed chapters to 44 textbooks, written 197 posters, served as the principal investigator on 1054 studies, written 674 published papers, served on or contributed to 38 journal editorial boards, functioned as the editor-in-chief of the Journal of Cosmetic Dermatology for 10 years, and was a past member of the Board of Directors of the American Academy of Dermatology and the American Society for Dermatologic Surgery. She was elected Vice-President of the American Academy of Dermatology. She is recognized as a pioneer in cosmetic dermatology and received a lifetime achievement award from Health Beauty America for her research and the 2008 DermArts award for her contributions to dermatology. In 2010, she received the Albert Kligman Innovation Award and in 2016 she was awarded a Presidential Citation from the American Academy of Dermatology for her research contributions to advance the specialty. She received the prestigious Maison deNavarre award from the Society of Cosmetic Chemists for her contributions to the art and science of cosmetics in 2017. In 2019, she was the inaugural recipient of the Florence Wall Award from the Society of Cosmetics Chemists naming her as the most influential women in cosmetic science.

➤ FOLLOW OUR NEW YOUTUBE: https://www.youtube.com/@AlmostSeriousTV ➤ DESCRIPTION: Here in America - things seem to only be getting worse by the day, and declining rapidly.. But thankfully, we have just the people in studio who can FIX all of our problems.. Gavin McInnes and Anthony Cumia join us for a special episode of NIGHTLY OFFENSIVE on RIFT TV!__⇩ SHOW SPONSORS⇩➤ VAN MAN COMPANY: Vanman Co. is the go-to source for all-natural, non-toxic and chemical free products — from creams to deodorant, soap and mouthwash, Vanman Co. is one of the only companies to deliver on quality without cutting corners when it comes to your health and well-being. Go to https://www.vanman.shop/elijah and use promocode ELIJAH for 10% OFF!➤ MYPILLOW: Mike Lindell and the MyPillow team are grateful for your continued support and are offering a special deal on their Giza Dreams and Percale bed sheets, originally intended for box stores this spring. After the stores backed out, MyPillow is passing the savings directly to you with wholesale prices: Giza Dream Queen size sheets are now $69.99 (down from $139.98) and King size $79.99, while Percale Queen size sheets are $29.98 (down from $89.98) and King size $34.98. To take advantage of these offers, visit https://www.MyPillow.com, scroll to the radio/podcast square, and use promo code ELIJAH, or call 800-210-8491 for free shipping options. Hurry, as this limited allotment won't last long—once they're gone, they're gone!➤ NUTRONICS LABS: USE PROMOCODE: ELIJAH | https://www.tboostnow.com ➤ 1775 Coffee: https://www.1775coffee.com/RIFT ➤ SPORT DRINK: https://sport-drink.com/?ref=elijah ➤ Locals: https://www.elijahschaffer.locals.com ___⇩ELIJAH'S SOCIAL MEDIA ⇩➤ X: https://X.com/ElijahSchaffer ➤ RUMBLE: https://rumble.com/c/SlightlyOffensive ➤ INSTA: https://www.instagram.com/slightlyoffensive.tv ➤ TELEGRAM https://t.me/SlightlyOffensive ➤ GAB: https://gab.com/elijahschaffer ___⇩ FOLLOW GAVIN ⇩➤ CENSORED: https://censored.tv/watch/show/get-off-my-lawn __⇩ FOLLOW ANTHONY CUMIA ⇩➤ X: https://x.com/AnthonyCumia ➤ CENSORED: https://censored.tv/watch/show/tacs ➤BOOKINGS + BUSINESS INQUIRIES: MIKE@SLIGHTLYOFFENSIVE.COMSupport the show

In this episode, you'll hear about the latest developments in tailoring cancer treatments to individual patients using Precision Oncology.  Two thought leaders, Simone Ndujiuba, a Clinical Oncology Pharmacist at Prime Therapeutics, and Karan Cushman, Head of Brand Experience and host of The Precision Medicine Podcast for Trapelo Health, discuss real-world research that is paving the way for Prime and our partners to help providers reduce turnaround times so patients can start treatment as soon as possible.  Join your host Maryam Tabatabai as they dig into this evolving topic of precision oncology. www.primetherapeuitics.com ⁠Chapters⁠Defining precision medicine (08:50)Evaluating real-world operational process of biomarker testing (14:36)Turnaround times are crucial (17:40)A patients view into the importance of time (24:39)Technology and process aid in time and process (29:30)Helping bridge knowledge gaps for providers and payers (33:55) The focus is on Precision Oncology right now (37:00)Precision medicine in other disease categories (40:09)Future of precision oncology is bright (42:07) References Singh, B.P., et al. (2019). Molecular profiling (MP) for malignancies: Knowledge gaps and variable practice patterns among United States oncologists (Onc). American Society of Clinical Oncology. https://meetings. asco.org/abstracts-presentations/173392 Evangelist, M.C., et al. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study. Journal of Clinical Oncology, 41(Supplement 16). https://doi.org/10.1200/JCO.2023.41.16_suppl.9109. Ossowski, S., et al. (2022). Improving time to molecular testing results in patients with newly diagnosed, metastatic non-small cell lung cancer. Journal of Clinical Oncology, 18(11). https://doi.org/10.1200/OP.22.00260 Naithani N, Atal AT, Tilak TVSVGK, et al. Precision medicine: Uses and challenges. Med J Armed Forces India. 2021 Jul;77(3):258-265. doi: 10.1016/j.mjafi.2021.06.020.  Jørgensen JT. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy. Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054.  MedlinePlus. What is genetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/genetics/understanding/testing/genetictesting/. MedlinePlus. What is pharmacogenetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/lab-tests/pharmacogenetic-tests/#:~:text=Pharmacogenetics%20(also%20called%20pharmacogenomics)%20is,your%20height%20and%20eye%20color.  Riely GJ, Wood DE, Aisner DL, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: non-small cell lung cancer, V3.2005. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.  Benson AB, Venook AP, Adam M, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: colon cancer, V3.2025. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Rosenberg PS, Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731. PMID: 38857048; PMCID: PMC11165384. Smeltzer MP, Wynes MW, Lantuejoul S, et al. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol. 2020 Sep;15(9):1434-1448. doi: 10.1016/j.jtho.2020.05.002.The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice.

As Admin Month ends, let's focus on community: how to find your support system and maintain a network that fuels your professional growth. Recorded at EA Ignite Fall 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

A natural storyteller and lifelong traveler, Mark Allen's career as a performer, composer, producer and engineer makes him universally at ease, whether in the pubs of the UK or onstage at the Grand Ole Opry. His ability to connect with strangers over the shared love of song has made him one of the longest-running performers at the Gaylord Opryland Resort entertaining international audiences —and hundreds of thousands of people— since 2006.While his passion as a producer/musician includes the founding of Atlanta's Benchmark Productions (1992), Mark's chapter in Nashville began in 1998, when recruited to run the studio of the American Society of Composers, Authors and Publishers (ASCAP). Over his career, he has scored films and released several critically acclaimed albums, including “American in the 21st Century,” and held residency as a premier writer/artist at CAL IV/Spirit Entertainment. His background in music, community outreach, production and engineering gives him fluency in music of every genre and, coupled with his love of travel, paved the way for his most recent creation: the new series Have Guitar Will Travel World, presented by Nashville PBS and available on public television nationwide beginning May 2025.https://www.haveguitarwilltravel.world/https://www.facebook.com/haveguitarwilltravelworld/https://www.aptonline.org/catalog/HAVE-GUITAR-WILL-TRAVEL-WORLD"Still on the Run" - https://www.fbrmusic.com/Host - Trey MitchellIG - treymitchellphotography IG - feeding_the_senses_unsensoredFB - facebook.com/profile.php?id=100074368084848Threads - www.threads.net/@treymitchellphotographySponsorship Information/Guest Suggestions  -  ftsunashville@gmail.com

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Evan Matros, MD, discuss the following articles from the May 2025 issue:   “The Financial Impact of a Cosurgeon in Breast Microsurgery” by DeVito, Ke, Park, et al.   “Legislative Impact and Persistent Disparities: Postmastectomy Breast Reconstruction Rates in the United States among 224,506 Patients” by Schafer, Ho, Potoczak, et al.   “Computer-Aided Design and Manufacturing in Free Fibula Reconstruction of the Mandible: Comparison of Long-Term Outcomes with the Conventional Technique” by Bengur, Humar, Saadoun, et al.   Special guest, Evan Matros, MD is an attending surgeon, Vice Chair of Health Information Technology in the Department of Surgery, and the program director of the microsurgery fellowship at the Memorial Sloan Kettering Cancer Center in New York City. He completed his General Surgery and Plastic Surgery Residencies at Harvard Medical School followed by a microsurgery fellowship at Memorial Sloan Kettering Cancer Center. He also has received his MPH at Columbia University and Master of Medical Science degree from Harvard Medical School. Among his many accomplishments, Dr. Matros is the current vice president of the American Society for Reconstructive Microsurgery Council, he currently serves on the editorial board of the PRS Journal, and he is widely published in reconstructive microsurgery.   READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCMay25Collection   The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.